These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28470188)

  • 1. RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.
    Wang XY; Li SN; Zhu HF; Hu ZY; Zhong Y; Gu CS; Chen SY; Liu TF; Li ZG
    Sci Rep; 2017 May; 7():46078. PubMed ID: 28470188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-κB signaling pathway.
    Sun Q; Yao X; Ning Y; Zhang W; Zhou G; Dong Y
    Tumour Biol; 2013 Oct; 34(5):2995-3002. PubMed ID: 23715780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
    Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
    Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.
    Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
    Mol Cell Biochem; 2014 Sep; 394(1-2):109-18. PubMed ID: 24833469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-145 downregulates SIP1-expression but differentially regulates proliferation, migration, invasion and Wnt signaling in SW480 and SW620 cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    J Cell Biochem; 2018 Feb; 119(2):2022-2035. PubMed ID: 28833449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway.
    Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Han JB; Kong YG; Tao ZZ; Chen SM
    Exp Cell Res; 2019 Jan; 374(1):172-180. PubMed ID: 30496758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
    He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
    Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
    Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
    BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 19. LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway.
    Wu N; Jiang M; Liu H; Chu Y; Wang D; Cao J; Wang Z; Xie X; Han Y; Xu B
    Cell Death Differ; 2021 Jan; 28(1):219-232. PubMed ID: 32737443
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.